Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

PEMMARAJU, NAVEEN

One or more keywords matched the following items that are connected to PEMMARAJU, NAVEEN

Item Type	Name
Concept	Primary Myelofibrosis
Academic Article	Primary autoimmune myelofibrosis (MF) with high-grade peripheral T-cell lymphoma (PTCL) NOS.
Academic Article	Phase II study of pomalidomide in combination with prednisone in patients with myelofibrosis and significant anemia.
Academic Article	Clinical significance of microcytosis in patients with primary myelofibrosis.
Academic Article	Durable remission with rituximab in a patient with an unusual variant of Castleman's disease with myelofibrosis-TAFRO syndrome.
Academic Article	Ruxolitinib in combination with lenalidomide as therapy for patients with myelofibrosis.
Academic Article	Therapeutic benefit of decitabine, a hypomethylating agent, in patients with high-risk primary myelofibrosis and myeloproliferative neoplasm in accelerated or blastic/acute myeloid leukemia phase.
Academic Article	Evidence for Janus kinase (JAK) inhibitors for the prevention of major morbid events in patients with myeloproliferative neoplasms (MPNs).
Academic Article	Durable remission with rituximab in a patient with an unusual variant of Castleman's disease with myelofibrosis-TAFRO syndrome
Academic Article	Ruxolitinib in combination with lenalidomide as therapy for patients with myelofibrosis
Academic Article	Haptoglobin is frequently low in patients with myelofibrosis: Clinical relevance.
Academic Article	Patients with post-essential thrombocythemia and post-polycythemia vera differ from patients with primary myelofibrosis.
Academic Article	Significance of thrombocytopenia in patients with primary and postessential thrombocythemia/polycythemia vera myelofibrosis.
Academic Article	Patient characteristics and outcomes in adolescents and young adults with classical Philadelphia chromosome-negative myeloproliferative neoplasms.
Academic Article	Association of bone marrow fibrosis with inferior survival outcomes in chronic myelomonocytic leukemia.
Academic Article	A phase 2 study of pracinostat combined with ruxolitinib in patients with myelofibrosis.
Academic Article	A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis.
Academic Article	Mixed myeloid chimerism and relapse of myelofibrosis after allogeneic stem cell transplantation.
Academic Article	Prognostic value of blasts in peripheral blood in myelofibrosis in the ruxolitinib era.
Academic Article	Clinical Significance of Bone Marrow Blast Percentage in Patients With Myelofibrosis and the Effect of Ruxolitinib Therapy.
Academic Article	Phase II study of single-agent nivolumab in patients with myelofibrosis.
Academic Article	Final results of a phase 2 clinical trial of LCL161, an oral SMAC mimetic for patients with myelofibrosis.
Academic Article	SOHO State of the Art Updates and Next Questions: Novel Therapies in Development for Myelofibrosis.
Academic Article	Ruxolitinib Re-Treatment in Patients with Myelofibrosis: Real-World Evidence on Patient Characteristics and Outcomes.
Academic Article	Addition of Navitoclax to Ongoing Ruxolitinib Therapy for Patients With Myelofibrosis With Progression or Suboptimal Response: Phase II Safety and Efficacy.
Academic Article	Improved survival of patients with myelofibrosis in the last decade: Single-center experience.
Academic Article	Defining disease modification in myelofibrosis in the era of targeted therapy.
Academic Article	Addition of navitoclax to ongoing ruxolitinib treatment in patients with myelofibrosis (REFINE): a post-hoc analysis of molecular biomarkers in a phase 2 study.
Academic Article	Clinicopathologic spectrum of myeloid neoplasms with concurrent myeloproliferative neoplasm driver mutations and SRSF2 mutations.
Academic Article	Impact of SF3B1 mutation in myelofibrosis.
Academic Article	Risk-adjusted safety analysis of the oral JAK2/IRAK1 inhibitor pacritinib in patients with myelofibrosis.
Academic Article	Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation: a Position Paper on behalf of the Chronic Malignancies Working Party of the EBMT.
Academic Article	Ten years after ruxolitinib approval for myelofibrosis: a review of clinical efficacy.
Academic Article	The role of therapy in the outcome of patients with myelofibrosis.
Academic Article	Moving toward disease modification in polycythemia vera.
Academic Article	Relevant Clinical Factors in Patients with Myelofibrosis on Ruxolitinib for 5 or More Years.
Academic Article	New era for myelofibrosis treatment with novel agents beyond Janus kinase-inhibitor monotherapy: Focus on clinical development of BCL-XL /BCL-2 inhibition with navitoclax.
Academic Article	Sotatercept for anemia of myelofibrosis: a phase II investigator-initiated study.

Search Criteria

Primary Myelofibrosis